Mohammad R. Saeed

Mr. Mohammad R. Saeed

PRX Research, Mesquite, Texas, USA
orcid
Researcher at PRX Research

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
MSMuhammad A. Saeed
Muhammad A. Saeed
AZAdeena Zaidi
Adeena Zaidi
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
HKHarris Javaid Khokhar
Harris Javaid Khokhar
BSBinish Arif Sultan
Binish Arif Sultan
HMHarris Majid
Harris Majid
Anemia has been a growing concern for the pediatric population in sub-Saharan Africa. Emerging risk factors for anemia under five years of age in low-income countries are multifaceted, including infectious diseases, nutritional deficiencies, hidden hunger, and various economic determinants, and its health burdens include childhood stunting and reduced cognitive function diminished school performance in children. However, the influence of climatic factors, particularly ambient temperatures, on pediatric anemia remains understudied. In this population-based study, we assess the region-specific associations between pediatric anemia and ambient temperatures in 43 countries in Africa from 2000 to 2019. Using generalized linear regression models (upon adjusting for covariates), we found that the risk of temperatures on pediatric anemia varies across four African regions, whereby the Central and Southern African regions have a positive association between pediatric anemia and ambient temperatures, and Western and Eastern regions are negatively affected. The study aims to provide evidence to stakeholders to curtail the onset of pediatric anemia in high-risk African regions to set up key interventions based on the sustainability goals set by the World Health Organization.

1 January 2024 in Fortune Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
MSMuhammad A. Saeed
Muhammad A. Saeed
BSBinish Arif Saltan
Binish Arif Saltan
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
HKHarris Khokhar
Harris Khokhar
AZAdeena Zaidi
Adeena Zaidi
FMFarhad Marzook
Farhad Marzook
The SARS-CoV-2 virus (COVID-19) has led to an initiative to develop safe and effective vaccines for public health safety. In December 2020, the United States Food and Drug Administration (FDA) administered an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID- 19 vaccine. Other vaccines from Johnson & Johnson, Moderna, and AstraZeneca shortly followed. This paper aims to examine the EUA process for COVID-19 vaccine approvals, including the requirements for the safety and efficacy of data, along with the role of the FDA and EMA in the approval process. Further, public concerns about vaccine approvals, including issues on the approval process's safety, efficacy, and speed, were also discussed. Using qualitative analysis of the extracted studies, trends and insights into the factors influencing public acceptance of COVID- 19 vaccines, such as vaccine hesitancy and misinformation, were discussed. Overall, a transparent and rigorous regulatory process for vaccine approval is critical for education efforts between policymakers, vaccine developers, and the public to address concerns for increased population vaccine uptake.

12 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMuhammad Saeed
Muhammad Saeed
AZAdeena Zaidi
Adeena Zaidi
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
HKHarris Javaid Khokhar
Harris Javaid Khokhar
SKSami Khan
Sami Khan
HMHarris Majid
Harris Majid
Emerging risk factors for childhood (<5 years) anemia cases in low-income countries have not been limited to COVID-19 and the spread of infectious diseases, hidden hunger, and other economic factors. Yet the effects of climatic factors, such as ambient temperatures, on child anemia have been in its infancy. In this population-based study, we study the region-specific associations between child anemia and ambient temperatures in 43 countries of Africa from 2000-2019. Using generalized linear regression models, we found that after adjusting for key covariates, the risk that temperatures pose on child anemia varies across the four African regions (Western, Eastern, Central, and Southern). This suggests that ambient temperatures have varying effects on child anemia by region. Other studies are needed in other low-income settings to expand our findings.

16 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMuhammad A. Saeed
Muhammad A. Saeed
FMFarhad Marzook
Farhad Marzook
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
HMHarris Majid
Harris Majid
MUMohammad Usman
Mohammad Usman
BSBinish Arif Sultan
Binish Arif Sultan
The SARS-CoV-2 virus (COVID-19) has led to an initiative to develop safe and effective vaccines for public health safety. In December 2020, the United States Food and Drug Administration (FDA) administered an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. Other vaccines from Johnson & Johnson, Moderna, and AstraZeneca shortly followed. This paper aims to examine the EUA process for COVID-19 vaccine approvals, including the requirements for the safety and efficacy of data, along with the role of the FDA and EMA in the approval process. Further, public concerns about vaccine approvals, including issues on the approval process's safety, efficacy, and speed, were also discussed. Using qualitative analysis of the extracted studies, trends and insights into the factors influencing public acceptance of COVID-19 vaccines, such as vaccine hesitancy and misinformation, were discussed. Overall, a transparent and rigorous regulatory process for vaccine approval is critical for education efforts between policymakers, vaccine developers, and the public to address concerns for increased population vaccine uptake.

14 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMuhammad A Saeed
Muhammad A Saeed
HKHarris Javaid Khokhar
Harris Javaid Khokhar
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
AZAdeena Zaidi
Adeena Zaidi
BSBinish Arif Sultan
Binish Arif Sultan
SKSami Khan
Sami Khan
Preliminary evidence suggests air pollution, particularly fine particulate matter 2.5 (PM2.5), poses a significant threat to maternal health and women of reproductive age. While emerging evidence suggests a link between air pollution and maternal anemia, the specific effect of PM2.5 exposure on hemoglobin levels among reproductive-aged women (15-49 years) remains insufficiently studied. Maternal hemoglobin decline is a known risk factor for adverse pregnancy outcomes with potentially long-term consequences. Understanding the impact of PM2.5 exposure is crucial in regions like Sub-Saharan Africa, where both anemia rates and air pollution levels are significantly elevated. This population-based study investigates the association between ambient PM2.5 concentrations and maternal hemoglobin levels across 43 Sub-Saharan African countries from 2000-2019. Using generalized linear regression models adjusted statistically significant negative association between PM2.5 exposure and hemoglobin levels were observed in Central Africa, while no significant associations were found in Eastern, Western, or Southern Africa. These results suggest that PM2.5 may be an environmental determinant of maternal anemia, with effects that vary by geography. Further research is needed in understudied regions to validate and expand on these findings.

7 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMuhammad A. Saeed
Muhammad A. Saeed
Mohammad R. SaeedMohammad R. Saeed
Mohammad R. Saeed
XAXaviera Ayaz
Xaviera Ayaz
HMHarris Majid
Harris Majid
Background: Diabetes among adults is becoming a major public health crisis in the United States. Numerous authors have documented the rising prevalence of diabetes, with notable variations found within the United States at the census level, state, and county levels. Yet, there is a need to understand whether diabetes prevalence varies between urban centers within a particular state. Methods: This ecological study provides a longitudinal investigation of the prevalence of adult diabetes across five major metropolitan urban areas in Texas (Austin, Dallas, Fort Worth, Houston, and San Antonio) from 2011 to 2023. By utilizing data from the Behavioral Risk Factor Surveillance System (BRFSS) and statistical testing, we evaluate both the temporal trajectory and city-level geographic disparities of diabetes prevalence. Findings: Upon aggregating all five urban centers, the findings demonstrate a significant statewide increase (β=0.12, P=0.026) in diabetes prevalence over the thirteen-year study period. Furthermore, profound regional variations were observed, with San Antonio having a significantly (P<0.05) higher prevalence than Austin, Dallas, and Fort Worth, with the San Antonio area exhibiting the highest mean prevalence at 12.1% and the Austin area maintaining the lowest at 9%. Interpretation: This research emphasizes the necessity for synchronized public health policies that account for localized contexts while addressing the broader metabolic crisis facing the Texas urban corridor.